Targeting Resident Memory T Cells for Cancer Immunotherapy

by Charlotte Blanc, Sophie Hans, Thi Tran, Clemence Granier, Antonin Saldman, Marie Anson, Stephane Oudard, Stephane Oudard, Eric Tartour, Eric Tartour
Published 2018-07-01

Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer

by Elise F. Nassif, Constance Thibault, Stéphane Oudard, Jérôme Galon
Published 2021-01-01

Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments

by Adrien Procureur, Audrey Simonaggio, Jean-Emmanuel Bibault, Stéphane Oudard, Yann-Alexandre Vano
Published 2021-02-01

Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)

by Audrey Simonaggio, Nicolas Epaillard, Cédric Pobel, Marco Moreira, Stéphane Oudard, Yann-Alexandre Vano
Published 2021-01-01

Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis

by Reza Elaidi, Letuan Phan, Delphine Borchiellini, Philippe Barthelemy, Alain Ravaud, Stéphane Oudard, Yann Vano
Published 2020-06-01

Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors

by Soumaya Karaki, Marie Anson, Thi Tran, Delphine Giusti, Charlotte Blanc, Stephane Oudard, Eric Tartour
Published 2016-11-01

Correction to: Pericardial effusion under nivolumab: case-reports and review of the literature

by Anastasia Saade, Audrey Mansuet-Lupo, Jennifer Arrondeau, Constance Thibault, Mariana Mirabel, François Goldwasser, Stéphane Oudard, Laurence Weiss
Published 2019-12-01

Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients.

by Yann-Alexandre Vano, Stéphane Oudard, Marie-Agnès By, Pauline Têtu, Constance Thibault, Hail Aboudagga, Florian Scotté, Reza Elaidi
Published 2018-01-01

Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study

by Nicolas Delanoy, Debbie Robbrecht, Mario Eisenberger, Oliver Sartor, Ronald de Wit, Florence Mercier, Christine Geffriaud-Ricouard, Johann de Bono, Stéphane Oudard
Published 2021-03-01

Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit

by Adrien Joseph, Audrey Simonaggio, Annabelle Stoclin, Antoine Vieillard-Baron, Guillaume Geri, Stéphane Oudard, Jean-Marie Michot, Olivier Lambotte, Elie Azoulay, Virginie Lemiale
Published 2020-10-01

High milk consumption does not affect prostate tumor progression in two mouse models of benign and neoplastic lesions.

by Sophie Bernichtein, Natascha Pigat, Thierry Capiod, Florence Boutillon, Virginie Verkarre, Philippe Camparo, Mélanie Viltard, Arnaud Méjean, Stéphane Oudard, Jean-Claude Souberbielle, Gérard Friedlander, Vincent Goffin
Published 2015-01-01

Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors.

by Charlotte Guyader, Jocelyn Céraline, Eléonore Gravier, Aurélie Morin, Sandrine Michel, Eva Erdmann, Gonzague de Pinieux, Florence Cabon, Jean-Pierre Bergerat, Marie-France Poupon, Stéphane Oudard
Published 2012-01-01

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer

by Cedric Pobel, Edouard Auclin, Diego Teyssonneau, Brigitte Laguerre, Mathilde Cancel, Elouen Boughalem, Johanna Noel, Pierre Emmanuel Brachet, Denis Maillet, Philippe Barthelemy, Carole Helissey, Constance Thibault, Stéphane Oudard
Published 2021-09-01

Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study

by Nicolas Epaillard, Pauline Parent, Yohann Loriot, Pernelle Lavaud, E-B. Vera-Cea, Nieves Martinez-Chanza, Alejo Rodriguez-Vida, Clement Dumont, Rebeca Lozano, Rebeca Lozano, Casilda Llácer, Raffaele Ratta, Stephane Oudard, Constance Thibault, Edouard Auclin
Published 2021-05-01

Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors

by Mariana Mirabel, MD, PhD, Domitille Callon, MD, Patrick Bruneval, MD, PhD, Anne-Laure Lebreil, Msci, Elie Mousseaux, MD, PhD, Stéphane Oudard, MD, PhD, Jean-Sébastien Hulot, MD, PhD, Laurent Andreoletti, MD, PhD
Published 2020-09-01

Composite biomarkers defined by multiparametric immunofluorescence analysis identify ALK-positive adenocarcinoma as a potential target for immunotherapy

by Hélène Roussel, Eléonore De Guillebon, Lucie Biard, Marion Mandavit, Laure Gibault, Elisabeth Fabre, Martine Antoine, Paul Hofman, Michèle Beau-Faller, Hélène Blons, Claire Danel, Françoise Le Pimpec Barthes, Alain Gey, Clémence Granier, Marie Wislez, Pierre Laurent-Puig, Stéphane Oudard, Patrick Bruneval, Cécile Badoual, Jacques Cadranel, Eric Tartour
Published 2017-04-01

The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival

by Elise F. Nassif, Bernhard Mlecnik, Constance Thibault, Marie Auvray, Daniela Bruni, Alexandre Colau, Eva Compérat, Gabriela Bindea, Aurélie Catteau, Aurélie Fugon, Isabelle Boquet, Marine Martel, Philippe Camparo, Pierre Colin, Roubini Zakopoulou, Aristotelis Bamias, Mostefa Bennamoun, Xavier Barthere, Bruno D’acremont, Marine Lefevre, Francois Audenet, Arnaud Mejean, Virginie Verkarre, Stéphane Oudard, Jérôme Galon
Published 2021-01-01